Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.


Library CD
Volume 8, 2004 Archive
Six back issues from 2004 on one convenient archive.
Permanent storage and easy retrieval of IJPC articles and formulations.
  • Print journal articles in color from the PDF file for your marketing needs.
  • Eliminate long searches through past issues for formulations, compatibility studies, standard operating procedures, marketing ideas, and literature reviews.

Only $200.00


(Select Format)
Instant PDF Download

This archive contains the following articles listed by volume, issue and page number:

Issues Included
Volume/Issue Date Title
Vol. 8 No. 1 January/February 2004 Androgen Deficiency in Women
Vol. 8 No. 2 March/April 2004 Overview of USP Chapter <797>
Vol. 8 No. 3 May/June 2004 Andropause
Vol. 8 No. 4 July/August 2004 Wound Care
Vol. 8 No. 5 September/October 2004 Topical Treatments in Wound Healing
Vol. 8 No. 6 November/December 2004 Endotoxin

Volume 8, 2004 Articles

Volume 8, 2004 Articles
Title (Click for Details) Vol/Issue Page
Prescription-Who and/or What is IJPC and the subject of pharmacy practice and compounding pharmacy-From the Editor Vol. 8 No. 1 2
Book & Literature Reviews Vol. 8 No. 1 4
Women's Oral Health: Is There a Hormonal Link? Vol. 8 No. 1 10
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 1 Vol. 8 No. 1 16
Prevention Is the Best Medicine: Don J. Bottoni, RPh, FACA, FIACP Vol. 8 No. 1 22
Detailing Your Compounding Specialty Practice: Part 1 - Prospecting, Preapproach and Approach Vol. 8 No. 1 31
Developing and Providing Compounding Services for Hospitals Involved in a Merger Vol. 8 No. 1 36
American Pharmaceutical Patents From a Historical Perspective Vol. 8 No. 1 40
Basics of Compounding for Disorders of the External Ear Vol. 8 No. 1 46
Urea and Hydrogen Peroxide Otic Solution Vol. 8 No. 1 47
Boric Acid 2% in Isopropyl Alcohol Vol. 8 No. 1 47
Aluminum Acetate Otic Solution Vol. 8 No. 1 47
Hydrocortisone and Acetic Acid Otic Solution Vol. 8 No. 1 47
Acetic Acid and Glycerin Otic Solution Vol. 8 No. 1 47
Ciprofloxacin 1% Otic Drops Vol. 8 No. 1 47
Gentamicin Sulfate 0.1% Otic Solution Vol. 8 No. 1 47
Lidocaine HCl 0.5% Otic Solution Vol. 8 No. 1 47
Neomycin Sulfate 0.5%, Polymyxin B Sulfate 10,000-U/mL and Hydrocortisone 1% Otic Solution Vol. 8 No. 1 47
Nystatin 100,000-units/mL Otic Suspension Vol. 8 No. 1 47
Triamcinolone 0.1% Otic Solution Vol. 8 No. 1 47
Handling of Syringes and Needles Vol. 8 No. 1 49
Calculations Vol. 8 No. 1 50
Aminopyridine 5-mg Capsules Vol. 8 No. 1 51
Boric Acid 600-mg Vaginal Suppository Vol. 8 No. 1 52
Diaminopyridine 10-mg Capsules Vol. 8 No. 1 53
Glycerin 50% Injection Vol. 8 No. 1 54
Hydrochloric Acid 0.1-N Injection Vol. 8 No. 1 55
Hydrocortisone 2-mg/mL Oral Liquid Vol. 8 No. 1 56
Phenol 5%-in-Oil Injection Vol. 8 No. 1 57
Scopolamine Hydrobromide 0.2% Nasal Spray Vol. 8 No. 1 58
Selegiline HCl 10-mg/mL in Pluronic Lecithin Organogel Vol. 8 No. 1 59
Vancomycin HCl and Heparin Sodium Injection Vol. 8 No. 1 60
Quality-Control Analytical Methods: Selecting an Analytical Method Vol. 8 No. 1 61
Metro Atlanta Board - Certified Specialists' Attitudes Toward Compounding Pharmacy Vol. 8 No. 1 65
Stability of Zidovudine and Dobutamine HCl Injections in 0.9% Sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinyl Chloride Bags Up to 24 Hours Vol. 8 No. 1 73
Scientific and Professional Reviewers for 2002/2003 Vol. 8 No. 1 77
PostScription: The Wedgewood Case: What It Means for Pharmacies Vol. 8 No. 1 79
Prescription - USP <795>, NABP and the Physician/patient/pharmacist relationship - From the Editor Vol. 8 No. 2 82
Literature Reviews Vol. 8 No. 2 84
Overview of Chapter <797> "Pharmaceutical Compounding - Sterile Preparations": The Potential Impact for Compounding Pharmacists Vol. 8 No. 2 89
Androgen Deficiency in Women: Understanding the Science, Controversy and Art of Treating Our Patients - Part 2 Vol. 8 No. 2 96
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Vol. 8 No. 2 101
Profile of a Practice: Stephen J. Newton, RPh, and PharmaTech Services, Inc., Avon, Colo. Vol. 8 No. 2 107
Detailing Your Compounding Specialty Practice - Part 2: The Presentation Vol. 8 No. 2 113
Financially Speaking: Business Continuation Planning Vol. 8 No. 2 120
An Excel Spreadsheet for Estimating Sodium-Chloride Equivalents for Drugs Vol. 8 No. 2 123
Basics of Compounding for the Treatment of Warts Vol. 8 No. 2 126
Calibration/Validation of Incubator Temperature Vol. 8 No. 2 130
Calculations Vol. 8 No. 2 132
Dexamethasone 0.04% Topical Spray Vol. 8 No. 2 133
Flucytosine 10-mg/mL Oral Liquid Vol. 8 No. 2 134
Griseofulvin 25-mg/mL Oral Liquid Vol. 8 No. 2 135
Hydromorphone HCl 20-mg/mL and Bupivacaine HCl 7.5-mg/mL Injection Vol. 8 No. 2 136
Miconazole 10-mg Troches Vol. 8 No. 2 137
Netilmicin 0.455% Ophthalmic Solution Vol. 8 No. 2 138
Pyridoxine HCl 100-mg/mL Injection, Preservative Free Vol. 8 No. 2 139
Stomatitis Mouthwash Vol. 8 No. 2 140
Tacrolimus 0.5-mg/mL Oral Liquid Vol. 8 No. 2 141
Tiagabine 1-mg/mL Oral Liquid Vol. 8 No. 2 142
Quality-Control Analytical Methods: Osmolality and Osmometry Vol. 8 No. 2 143
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Vol. 8 No. 2 147
Chemical Stability of Phenylephrine HCl After Reconstitution in 0.9% Sodium Chloride Injection for Infusion Vol. 8 No. 2 153
Effect of Freezing, Long-Term Storage and Microwave Thawing on the Stability of Tramadol in 5% Dextrose Infusion in Polyvinyl Chloride Bags Vol. 8 No. 2 156
PostScription: Cleanroom Standards Vol. 8 No. 2 160
Prescription - Pharmacy and the United States Pharmaceopeia-National Formulary - From the Editor Vol. 8 No. 3 162
Book and Literature Reviews Vol. 8 No. 3 164
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 Vol. 8 No. 3 169
Andropause: New Perspectives Vol. 8 No. 3 175
Compounding in the Pharmacy Curriculum: Beyond the Basics Vol. 8 No. 3 181
Migraine Headache Suppositories Vol. 8 No. 3 184
Nitrofurantoin Uretheral Inserts Vol. 8 No. 3 184
Acyclovir Lip Balm Vol. 8 No. 3 184
Gag Tablet Lollipops Vol. 8 No. 3 184
Atropine 1-mg Gelatin Troches Vol. 8 No. 3 184
Phenylpropanolamine HCl 10-mg Chewable Troches for Dogs Vol. 8 No. 3 184
Dicyclomine HCl 1-mg and Diphenhydramine HCl 10-mg Anesthetic Troches Vol. 8 No. 3 184
Amphotericin B 2-mg/mL Ophthalmic Solution Vol. 8 No. 3 185
Morphine Sulfate 5-mg/0.1-mL Nasal Spray Vol. 8 No. 3 185
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops Vol. 8 No. 3 185
Nifedipine 20% Vasodilating Gel Vol. 8 No. 3 185
Scopolamine Hydrobromide 0.25-mg/0.1-mL Topical Gel Vol. 8 No. 3 185
Estrogen 0.625-mg/5-g Vaginal Gel Vol. 8 No. 3 185
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) Vol. 8 No. 3 185
Pain Management in the Elderly Vol. 8 No. 3 187
Precepting: A Win-Win Situation for All Vol. 8 No. 3 194
A Foot in the Door: Building Relationships Builds Your Business Vol. 8 No. 3 197
Automatic Dishwashers and Detergents in the Pharmacy: The Basics Vol. 8 No. 3 200
Pharmaceutical Compounding Calculations Vol. 8 No. 3 203
Basics of Compounding for Cold Sores or Fever Blisters Vol. 8 No. 3 206
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medication Stick (Water-soluble base) Vol. 8 No. 3 208
Acyclovir 5%, Lidocaine 1% and Sodium Lauryl Sulfate 5% Medications Stick (Water-proof base) Vol. 8 No. 3 208
Emollient Lip Balm with 5% Benzocaine Vol. 8 No. 3 208
Fever Blister Ointment Vol. 8 No. 3 208
Deoxy-D-Glucose 0.2%, Lidocaine HCl 5% and Sodium Lauryl Sulfate 5% Cream Vol. 8 No. 3 208
Lemon Balm 1% Cream Vol. 8 No. 3 209
Acyclovir 5% and Lidocaine HCl 2% Topical Gel Vol. 8 No. 3 209
Acyclovir 5% and Sodium Lauryl Sulfate 5% Topical Gel Vol. 8 No. 3 209
Foscarnet 3% and Sodium Lauryl Sulfate 5% Topical Gel Vol. 8 No. 3 209
Acyclovir 5% and Dexamethasone 0.1% Topical Gel Vol. 8 No. 3 209
Foscarnet 3% and Triamcinolone Acetonide 0.1% Topical Gel Vol. 8 No. 3 209
Standard Operating Procedure: Disposal of Chemicals Vol. 8 No. 3 210
Calculations Vol. 8 No. 3 211
Alpha Hydroxy Acids Lotion Vol. 8 No. 3 213
Amiodarone HCl 5-mg/mL Oral Liquid Vol. 8 No. 3 214
Atenolol 2-mg/mL Oral Liquid Vol. 8 No. 3 215
Clonidine HCl 1.5-mg/mL Injection Vol. 8 No. 3 216
Fluorouracil 1% Ophthalmic Solution Vol. 8 No. 3 217
Glycopyrrolate 0.5-mg/mL Oral Liquid Vol. 8 No. 3 218
Ketoprofen 50-mg Suppository Vol. 8 No. 3 219
Morphine Sulfate 25-mg/mL and Ketamine HCl 25-mg/mL Injection Vol. 8 No. 3 220
Sumatriptan 25-mg Suppository Vol. 8 No. 3 221
Testosterone Propionate 100-mg/mL in Oil Injection Vol. 8 No. 3 222
Quality-Control Analytical Methods: High-Performance Liquid Chromatography Vol. 8 No. 3 223
Physical and Chemical Stability of Trepostinil Sodium Injection Packaged in Plastic Syringe Pump Reservoirs. Vol. 8 No. 3 228
Long-Term Stability of Trimix: A Three-Drug Injection Used to Treat Erectile Dysfunction. Vol. 8 No. 3 231
Stability of Zidovudine and Ranitidine in 0.9% sodium Chloride and 5% Dextrose Injections Stored at Ambient Temperature (23 ± 2°C) and 4°C in 50-mL Polyvinylchloride Bags Up to 24 Hours. Vol. 8 No. 3 236
PostScription: How should a pharmacist be trained? Vol. 8 No. 3 240
PreScription - Categories of Pharmaceutial Compounding Vol. 8 No. 4 242
Book and Literature Reviews Vol. 8 No. 4 244
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Vol. 8 No. 4 251
Case Report: Wound Care of a Diabetic Foot Ulcer Vol. 8 No. 4 265
Case Reports: Their Impact Vol. 8 No. 4 266
Current Topical Treatments in Wound Healing - Part 1 Vol. 8 No. 4 269
Warts: Facts and Therapy (Patient Handout) Vol. 8 No. 4 275
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Vol. 8 No. 4 277
Rationale for a Pharmacists' Pharmacopeia Vol. 8 No. 4 285
Basics of Compounding for Fungal Sinusitis Vol. 8 No. 4 289
Amphotericin 100-mcg/mL Nasal Irrigation/Spray Vol. 8 No. 4 290
Ketoconazole 1% Nasal Irrigation/Spray Vol. 8 No. 4 290
Miconazole 1% Nasal Irrigation/Spray Vol. 8 No. 4 290
Nystatin 50,000-Units/mL Nasal Irrigation Vol. 8 No. 4 290
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product Vol. 8 No. 4 292
Calculations Vol. 8 No. 4 294
Diltiazem 2% in Pluronic Lecithin Organogel Vol. 8 No. 4 295
Diphenhydramine HCl 0.1%, Lidocaine HCl 1%, Misoprostol 0.0024% and Triamcinolone Acetonide 0.12% Oral Rinse Vol. 8 No. 4 296
Estradiol 0.01% Wound Gel Vol. 8 No. 4 297
Lidocaine HCl 2%, Misoprostol 0.0024% and Phenytoin 2% Topical Wound Powder Vol. 8 No. 4 298
Metronidazole 2%, Misoprostol 0.0024% and Phenytoin 5% Topical Gel Vol. 8 No. 4 299
Metronidazole 2% Topical Gel Vol. 8 No. 4 300
Pentoxifylline 5% Topical Cream Vol. 8 No. 4 301
Tretinoin 0.1% and Lidocaine HCl 0.5% Topical Gel Vol. 8 No. 4 302
Veterinary Wound Dressing Vol. 8 No. 4 303
Wound Cleansing Spray Vol. 8 No. 4 304
Quality-Control Analytical Methods: Gas Chromatography Vol. 8 No. 4 305
Enhanced Release of Diazepam from Hollow-Type Suppositories Vol. 8 No. 4 310
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vol. 8 No. 4 313
PostScription: What is Evidence-Based Medicine? Vol. 8 No. 4 320
Prescription: Accreditation of Pharmacies and Certification of Pharmacists Vol. 8 No. 5 322
Book and Literature Reviews Vol. 8 No. 5 324
Domperidone in Lactation: Use as a Galactagogue Vol. 8 No. 5 329
Domperidone Capsules 10-, 20- and 30-mg Vol. 8 No. 5 332
Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications Vol. 8 No. 5 337
Head to Toe Solutions: A Quick Review of Current Therapies Vol. 8 No. 5 345
Aromatic Head Lice Oil Vol. 8 No. 5 346
Current Topical Treatments in Wound Healing - Part 2 Vol. 8 No. 5 354
Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 Vol. 8 No. 5 359
Wish You Were Here: American Institute of the History of Pharmacy, Madison, Wisconsin Vol. 8 No. 5 368
A Foot in the Door: Marketing Tips - Dealing With Personalities Vol. 8 No. 5 373
Basics of Compounding for Skin Discolorations Vol. 8 No. 5 376
Hydroquinone 5% Cream Vol. 8 No. 5 378
Hydroquinone 5% in Isopropyl Alcohol Vol. 8 No. 5 378
Hydroquinone 5% Topical Gel Vol. 8 No. 5 378
Hydroquinone 5% Topical Stick, Water Repellant Vol. 8 No. 5 378
Hydroquinone 5% Topical Stick, Water Soluble Vol. 8 No. 5 378
Dexamethasone 0.1%, Hydroquinone 5% and Retinoic Acid 0.1% Ointment Vol. 8 No. 5 378
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Gel Vol. 8 No. 5 378
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Cream Vol. 8 No. 5 378
Hydroquinone 5%, Retinoic Acid 0.1% and Triamcinolone 0.1% Ointment Vol. 8 No. 5 379
Hydrocortisone 1%, Hydroquinonne 5% and Glycolic Acid 5% Lotion Vol. 8 No. 5 379
Standard Operating Procedure: Pharmacy Computer System Access to and Maintenance of the Master Formula Records Vol. 8 No. 5 381
Calculations Vol. 8 No. 5 382
Acyclovir 5% and Chlorhexidine Diacetate 0.2% Topical Gel Vol. 8 No. 5 383
Benzalkonium Chloride 0.1% Topical Gel Vol. 8 No. 5 384
Camphor 0.3%, Menthol 0.3% and Phenol 0.3% Topical Gel Vol. 8 No. 5 385
Coal Tar 1% Topical Gel Vol. 8 No. 5 386
Diclofenac Sodium 1.5% Topical Gel Vol. 8 No. 5 387
Ibuprofen 2% Topical Gel Vol. 8 No. 5 388
Ketamine HCl 5% and Ketoprofen 5% in PLO Vol. 8 No. 5 389
Ketoprofen 5% and Loperamide 7.5% in PLO Vol. 8 No. 5 390
Resorcinol 1% and Salicylic Acid 3% Gel Vol. 8 No. 5 391
Salicylic Acid 6% Topical Gel Vol. 8 No. 5 392
Quality-Control Analytical Methods: USP Chapter <797> Compounded Sterile Preparations Sterility Requirements and Their Relationship to Beyond-Use Dating Vol. 8 No. 5 393
Compatibility and Stability of Aloxi (Palonosetron Hydrochloride) Admixed With Dexamethasone Sodium Phosphate Vol. 8 No. 5 398
Chemical Stability of Terbutaline Sulfate Injection After Diluting With Normal Saline When Stored at Room Temperature in Polyvinylchloride Bags Vol. 8 No. 5 404
PostScription: Your voice is important to the future of pharmacy Vol. 8 No. 5 407
PreScription: US Pharmacopeia-US Dispensatory: Pharmacist's Edition Vol. 8 No. 6 410
Book Review: HRT: The Answers. A Concise Guide for Solving the Hormone Replacement Therapy Puzzle Vol. 8 No. 6 412
Book Review: Good to Great: Why Some Companies Make the Leap and Others Don't Vol. 8 No. 6 412
Literature Reviews Vol. 8 No. 6 413
Measuring Testosterone Biomarkers in Serum and Saliva: Are They Accurate? Vol. 8 No. 6 419
The Salivary Hormone Profile in the Clinical Evaluation of Women Vol. 8 No. 6 427
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Vol. 8 No. 6 436
Compounding for Sports Medicine Vol. 8 No. 6 443
Is Veterinary Compounding Illegal Under Federal Law? Vol. 8 No. 6 449
Cleaning of Isolators: A Vital Part of a Contamination Control Program Vol. 8 No. 6 452
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid Vol. 8 No. 6 458
Basics of Compounding for Cough Vol. 8 No. 6 462
Standard Operating Procedure: Calculating the Endotoxin Load in Compounded Sterile Preparations Vol. 8 No. 6 466
Calculations Vol. 8 No. 6 468
BAD (Benadryl, Ativan, and Decadron) Intravenous Drip Vol. 8 No. 6 469
Diclofenac Sodium 25-mg/mL Injection Vol. 8 No. 6 470
Gentamicin Sulfate, Neomycin Sulfate, and Polymixin B Sulfate Bladder Irrigation Vol. 8 No. 6 471
Gentamicin Sulfate 0.2%, Misoprostol 0.0024%, and Phenytoin 5% Topical Gel Vol. 8 No. 6 472
Itraconazole 0.1% Nasal Irrigation Vol. 8 No. 6 473
Ketamine Hydrochloride and Fentanyl Citrate Injection Vol. 8 No. 6 474
Ketamine 25-mg/mL Nasal Spray Vol. 8 No. 6 475
Lidocaine Hydrochloride 4%, Epinephrine Hydrochloride 0.05%, and Tetracaine Hydrochloride 0.5% Topical Spray Vol. 8 No. 6 476
Ofloxacin 0.5% Topical Liquid Vol. 8 No. 6 477
Sodium Hypochlorite 0.025% Topical Solution Vol. 8 No. 6 478
Quality-Control Analytical Methods: Allowable Endotoxic Levels in Sterile Preparations Vol. 8 No. 6 479
Stability of Extemporaneous Oral Ribavirin Liquid Preparation Vol. 8 No. 6 486
Chemical Stability of Methadone Concentrate and Powder Diluted in Orange-Flavored Drink Vol. 8 No. 6 489
Preparation and Characterization of a Compounded Aqueous Human Insulin Suspension Vol. 8 No. 6 492
PostScription Vol. 8 No. 6 496